Clinical Trial Update: Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating disruption of the lymphoid tumor microenvironment prior to autologous stem cell transplantation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Lymphoma
• Multiple Myeloma

Snippet

Sponsor: Tufts Medical Center | Conditions: Chronic Lymphocytic Leukemia, Lymphoma | Phase 1 | Status: TERMINATED